Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

NCT00435955 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma

Interventions

PROCEDURE: High dose chemotherapy with autologous transplantation
DRUG: Rituximab

Sponsor

Azienda Ospedaliera San Giovanni Battista

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]